Search results
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 5 days agoThis new round of cuts will result in Pfizer incurring one-time charges totaling $1.7 billion, the...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 2 days agoThe dividend isn't the only thing attractive about this stock Keith Speights (Pfizer): Income...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 5 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 3 days agoPfizer Pfizer hasn't performed well recently. Despite its important role in developing effective...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
AOL· 2 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the virus. RSV, which typically causes cold-like ...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com
Investing.com· 7 days agoShares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 2 days agoGlobal vaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 2 days agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 5 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...